Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9N3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,748
Award facts
- Contract value 100% obligated
- $40,748.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40.7K delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Zepbound 10 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside delivery order is expected to be completed by January 13, 2026, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.999B through December 2026 that enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government agencies including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated consistent capability to meet federal procurement requirements through open competition across its extensive pharmaceutical portfolio, which includes specialty medications, vaccines, brand-name and generic drugs, and medical devices spanning multiple therapeutic domains. This delivery order for Zepbound—a GLP-1 receptor agonist used for weight management—aligns with the company's established role as a critical vendor for federal military and healthcare system pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FM9N3?
SPE2DR26FM9N3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM9N3 worth?
The government has obligated $40,748 on SPE2DR26FM9N3.
Is contract SPE2DR26FM9N3 an order under another contract?
Yes. SPE2DR26FM9N3 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9N3 competed?
The extent of competition for SPE2DR26FM9N3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award